NEPHROGENEX INC COM
NRX
NRX was delisted on the 10th of May, 2016.
14 hedge funds and large institutions have $18.1M invested in NEPHROGENEX INC COM in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCP
Rho Capital Partners
New York
|
+$13.5M |
| 2 |
VAM
Visium Asset Management
New York
|
+$4.86M |
| 3 |
RCMB
Revelation Capital Management (Bermuda)
Hamilton,
Bermuda
|
+$995K |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$510K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$400K |
Top Sellers
NRX Hedge Fund Activity: Q1 2014 in Review
14 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q1 2014, worth a combined $18.1M.
Buyers outnumbered sellers: 14 funds opened new NRX positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Rho Capital Partners, opening a new position worth an estimated $13.5M.
- 14 institutional investors held NEPHROGENEX INC COM (NRX) as of Q1 2014, up from 0 in Q4 2013.
- Funds reported $18.1M of NEPHROGENEX INC COM stock for Q1 2014.
- 14 funds opened new NEPHROGENEX INC COM positions in Q1 2014 and 0 closed out, a net change of +14 holders.
- The largest NEPHROGENEX INC COM buyer in Q1 2014 was Rho Capital Partners, an estimated $13.5M added.
Based on aggregated 13F filings for Q1 2014.